160 Health International soars 137% in HK trading debut

On September 17, 2025, 160 Health International Limited (HKG: 02656) made its debut on the Hong Kong Stock Exchange, closing up 137.34% at HK$28.22 with a turnover of HK$198 million. According to the offering announcement, the issue price was set at HK$11.89 per share. A total of 33.6455 million shares were issued, with each board lot consisting of 250 shares. The net proceeds from the offering reached approximately HK$316 million.

The prospectus indicates that 160 Health International is an experienced wholesaler of pharmaceutical and healthcare products in China and a leading integrated digital healthcare service provider. The company offers a wide range of pharmaceutical and healthcare products, as well as comprehensive digital healthcare solutions. Additionally, it provides digital healthcare services through its online platform—the 160 Health Platform—empowering all participants across the entire healthcare industry chain.

As of March 31, 2025, 160 Health International's platform has connected over 44,600 healthcare institutions since its establishment, including more than 14,400 hospitals (of which 3,430 are tertiary hospitals) and over 30,200 primary healthcare institutions. Among the company's partnered healthcare institutions, more than 6,800 private institutions primarily offer consumer healthcare services on its platform, such as dental, ophthalmology, and physical examination services.